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Dear Editor,
The use of medications concerns to patients and health
care professionals, and there may be errors with signiﬁcan
clinical repercussions.1 There are factors that contribute
to these errors: pluripathology, polymedication, healthcar
system fragmentation (with multiple prescribing physician
and absence of a single health record), as well as a lac
of knowledge of the treatment by the patient and/or th
family or caregivers. Several processes have been propose
to decrease these medication errors, including medication
reconciliation (creating a precise list of medication that com
piles all the drugs that the patient is taking), treatmen
review (evaluating the list for suitability, effectiveness, safet
and convenience in conjunction with the patient’s state o
health) and personalised therapeutic management (conﬁrm
ing adherence, knowledge of drugs and list of medication “in
the wallet”). Conciliation of the treatment should be done by 
multidisciplinary group (physicians, nurses and pharmacists
in all patients, including all medications, covering all health
care processes (in-hospital and as outpatient). Since this is DOI of original article:
http://dx.doi.org/10.1016/j.nefro.2015.10.021.
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eritoneal
costly process, priority has been given to patients with chronic
disease, polymedicated and with multiple pathologies, gen
erally in healthcare transition and for groups of drugs more
commonly involved in adverse reactions (with preference
given to drugs that should be reconciled within 4 h of admis
sion, drugs that should be reconciled within 24 h of admission
drugs with a narrow therapeutic index, drugs with multiple
interactions and drugs wit high-risk).2,3 Given that patients in
dialysis are at a high risk, we conducted a study to determine
which drugs were prescribed on our unit, as well as medication
adherence and knowledge on the part of the patients and/o
caregivers as a starting point for reconciliation.4–7
We  conducted a prospective, observational study on a
cohort of patients in peritoneal dialysis from February to May
2015. The following variables were collected: age, sex, time
in dialysis, comorbid conditions (diabetes mellitus, cardiovas
cular disease and hypertension), number of drugs, numbe
of pills per day, type of medication (drugs that required
reconciliation within 4 h of hospital admission, drugs tha
required reconciliation within 24 h of hospital admission
drugs with a narrow therapeutic index, drugs with multipleés Martín B, Herrera Gómez F, Santana Zapatero H, Diego Martín J,
apéutica en pacientes en diálisis peritoneal. Nefrología.
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Table 1 – Knowledge according to therapeutic group
(knowledge and abilities assessment scale adapted from
DRUGS and MedTake).
Drug Percentage of
patients treated
Percentage of
knowledge of
indication
Antidiabetic agents 23.5 100
Cardiological treatment 35.3 100
Antiplatelet agents 47.1 100
Analgesics 17.6 100
Sintrom® 11.76 100
Omeprazole 58.8 90
Antihypertensive agents 94.1 81.25
Furosemide 64.5 72.72
ESAs 82.4 71.4
Statins 64.5 63.63
Vitamin D 94.1 62.5
Phosphorus chelators 88.2 26.66
teractions and high-risk drugs) and number of prescribing
hysicians. Adherence was calculated using the Morisky-
reen questionnaire,8 and knowledge was calculated using
e knowledge and abilities assessment scale (adaptation of
scales, DRUGS and MedTake).9 Statistical analysis was per-
rmed with the SPSS® version 15.0 software programme.
The 17 patients enrolled, including 4 women (23.8%), had
mean age of 65.29 years (47–86), a mean time in dialysis of
.7 months (3–93) and the following comorbidity: diabetes
ellitus, 23.5%; cardiovascular disease, 23.5%; and hyperten-
on, 100%. The number of prescribing physicians in the last
 months was 8 (6–11). Medication-related data: number of
rugs, 12.59 (9–17); number of pills, 13.59 (8–27); drugs that
quired reconciliation within 4 h of admission, 13 (76.5%);
rugs that required reconciliation within 24 h of admission,
 (100%), drugs with multiple interactions, 16 (94.2%); drugs
ith a narrow therapeutic index, 3 (17.6%); high-risk drugs,
 (100%). Five patients (29.4%) required help with completion
f forms. Adherence was 76.6%, and overall lack knowledge
out the therapeutic indication was 52.94%. Table 1 shows
nowledge according to therapeutic group.
Our patients had a high risk of having problems related
 medication: multiple drugs, large number of pills per
ay and high number of prescribing physicians. The major-
y of patients received drugs that required reconciliation
ithin 4 h of admission with multiple interactions or high-
sk medicines. They showed a good level of adherence
6.6%), with a broad knowledge of cardiological medication
ntiplatelet agents, antiarrhythmic agents and anticoag-
lants), antihypertensive agents, gastroprotective agents,
tidiabetic agents and analgesics, and poor knowledge of
eatments related to complications of kidney disease and
ialysis (phophate binding and erythropoiesis-stimulating
ents [ESAs]).
C. Everett Koop, stated: “Drugs don’t work in patients who
on’t take them”. Therefore, it is advisable to generate a list
owing all the medicines that the patient is taking and how
e or she takes them and ensure that he or she is receiv-
g medication in appropriate, effective and safe manner for
is or her clinical situation, taking into account the indi-
tion for each drug and the convenience of taking it (the
20
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atients enrolled in our study had poor knowledge of drugs,
pecially drugs related to their kidney disease). The dialysis
ntre should be the “centre for health” and information on
edication, given that no physician knows the patient better
an the dialysis team. Errors should be detected at regu-
r intervals (3–4 months) or in each transition (visit to other
ecialists, change in medication or hospital admission), the
atient should receive a printed copy of the reconciled medica-
on list and, until there is a comprehensive electronic system,
e patient should be advised to carry in his or her wallet the
conciled medication list so that it is always available, for any
ealthcare personnel in any health ﬁeld.
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